News

November 02, 2021

An annual survey on inspections and audits has revealed opportunities to use more flexible approaches to optimize processes.

November 02, 2021

Takeda’s acquisition of GammaDelta Therapeutics expands their immuno-oncology and innate immune cell therapy portfolio.

November 02, 2021

Aceragen’s acquisition of Arrevus adds key treatment candidates to its rare disease pipeline.

November 02, 2021

Novartis’ scemblix (asciminib) is designed to provide a single treatment option to patients struggling with chronic myeloid leukemia.

November 02, 2021

Following the acquisition, Avantor will have access to Masterflex’s various bioproduction operations.

November 02, 2021

November 02, 2021

November 02, 2021

Manufacturing capacity expansion is high on the agenda for many bio/pharma companies and service providers in Europe.

November 01, 2021

Abbvie’s Vuity (pilocarpine HCI ophthalmic solution) is the first and only eye drop to receive FDA approval for the treatment of presbyopia.

November 01, 2021

The Pfizer-BioNTech COVID-19 vaccine is the first to receive FDA Emergency Use Authorization for use in children ages five to 11.